Ayrton Drugs

Ayrton Drug Manufacturing Limited was a Ghanaian pharmaceutical company. It was established on September 24, 1965. The business entity was listed on the stock index of the Ghana Stock Exchange, the GSE All-Share Index. The factory it ran is based in Tesano, a suburb of Accra. The company's product portfolio included anti-hypertensives, hematinics, dermatological preparations, antibiotics, dewormers, pain killers and anti-inflammatory drugs. In February 2010 Adcock Ingram, a South African pharmaceutical company acquired 66% shares in the company.[1]

Ayrton Drug Manufacturing Limited
GSE: AYRTN
IndustryPharmaceuticals
FoundedSeptember 24, 1965
Headquarters
Accra, Greater Accra, Ghana
Key people
Chairman- Nik Amarteifio, CEO- Daniel Apeagyei Kissi
ProductsTeedar, Samalin Cough syrup, Virol blood tonic, Ayrton Para caplets
Websitehttps://ayrtondrug.com (archived)

In January 2020, Ayrton Drug Manufacturing Limited and two other domestic pharmaceutical companies, Dannex Limited and Starwin Products Limited, had already merged and listed on the GSE as DAS Pharma.[2]

References
  1. "Ayrton Drugs Manufacturing Ltd". www.ghanastocks.net. Archived from the original on 23 June 2015. Retrieved 23 June 2015.
  2. Bruce, Emmanuel (16 January 2020). "Three local pharmaceutical companies merge lists on GSE as DAS Pharma. Three local pharmaceutical companies, Dannex Limited, Ayrton Drug Manufacturing Limited and Starwin Products Limited have merged and listed on the Ghana Stock Exchange as DAS Pharma". Graphic Online. Graphic Communications Group Ltd. Retrieved 6 December 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.